TherapeuticsMD, Inc. (TXMD)
NASDAQ: TXMD · Real-Time Price · USD
1.400
+0.017 (1.23%)
May 8, 2025, 4:00 PM - Market closed
TherapeuticsMD Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2015 - 2019 |
| Cash & Equivalents | 5.06 | 4.33 | 38.07 | 64.91 | 80.49 | Upgrade
|
| Cash & Short-Term Investments | 5.06 | 4.33 | 38.07 | 64.91 | 80.49 | Upgrade
|
| Cash Growth | 16.92% | -88.63% | -41.35% | -19.36% | -49.96% | Upgrade
|
| Receivables | 3.56 | 3.09 | - | - | 32.38 | Upgrade
|
| Inventory | - | - | - | - | 7.99 | Upgrade
|
| Prepaid Expenses | 0.07 | 0.25 | 1.17 | 2.73 | 2.57 | Upgrade
|
| Restricted Cash | - | - | 11.25 | - | - | Upgrade
|
| Other Current Assets | 3.57 | 4.13 | 4.87 | 51.83 | 4.98 | Upgrade
|
| Total Current Assets | 12.26 | 11.8 | 55.35 | 119.47 | 128.4 | Upgrade
|
| Property, Plant & Equipment | 6.1 | 6.87 | 7.66 | 9.06 | 11.51 | Upgrade
|
| Other Intangible Assets | 4.32 | 6.1 | 6.94 | 7.14 | 41.45 | Upgrade
|
| Long-Term Accounts Receivable | 16.01 | 18.48 | 20.25 | - | - | Upgrade
|
| Other Long-Term Assets | 0.13 | 0.06 | 0.25 | 33.8 | 0.25 | Upgrade
|
| Total Assets | 38.82 | 43.31 | 90.46 | 169.47 | 181.61 | Upgrade
|
| Accounts Payable | 0.26 | 0.03 | 2.16 | 3.37 | 21.07 | Upgrade
|
| Accrued Expenses | 0.49 | 1.66 | 12.76 | 9.12 | 28.86 | Upgrade
|
| Current Portion of Long-Term Debt | - | - | - | 188.27 | - | Upgrade
|
| Current Portion of Leases | 1.63 | 1.47 | 1.39 | 1.36 | 2.25 | Upgrade
|
| Other Current Liabilities | 2.78 | 3.69 | 30.53 | 50.77 | 7.06 | Upgrade
|
| Total Current Liabilities | 5.17 | 6.85 | 46.84 | 252.89 | 59.24 | Upgrade
|
| Long-Term Debt | - | - | - | - | 237.7 | Upgrade
|
| Long-Term Leases | 5.54 | 6.53 | 7.37 | 8.06 | 8.68 | Upgrade
|
| Other Long-Term Liabilities | 0.74 | 0.64 | 1.11 | 2.14 | - | Upgrade
|
| Total Liabilities | 11.45 | 14.02 | 55.32 | 263.09 | 305.61 | Upgrade
|
| Common Stock | 0.01 | 0.01 | 0.01 | 0.01 | 0.3 | Upgrade
|
| Additional Paid-In Capital | 979.18 | 978.92 | 974.5 | 957.73 | 754.64 | Upgrade
|
| Retained Earnings | -951.82 | -949.64 | -939.36 | -1,051 | -878.95 | Upgrade
|
| Shareholders' Equity | 27.37 | 29.29 | 35.14 | -93.62 | -124 | Upgrade
|
| Total Liabilities & Equity | 38.82 | 43.31 | 90.46 | 169.47 | 181.61 | Upgrade
|
| Total Debt | 7.18 | 8.01 | 8.76 | 197.69 | 248.63 | Upgrade
|
| Net Cash (Debt) | -2.12 | -3.68 | 29.31 | -132.79 | -168.14 | Upgrade
|
| Net Cash Per Share | -0.18 | -0.35 | 3.13 | -16.68 | -30.50 | Upgrade
|
| Filing Date Shares Outstanding | 11.57 | 11.53 | 9.95 | 8.67 | 7.76 | Upgrade
|
| Total Common Shares Outstanding | 11.53 | 11.53 | 9.5 | 8.6 | 6 | Upgrade
|
| Working Capital | 7.09 | 4.94 | 8.51 | -133.42 | 69.17 | Upgrade
|
| Book Value Per Share | 2.37 | 2.54 | 3.70 | -10.89 | -20.68 | Upgrade
|
| Tangible Book Value | 23.05 | 23.19 | 28.2 | -100.77 | -165.45 | Upgrade
|
| Tangible Book Value Per Share | 2.00 | 2.01 | 2.97 | -11.72 | -27.60 | Upgrade
|
| Machinery | - | - | 2.1 | 2.34 | 3.19 | Upgrade
|
| Leasehold Improvements | - | - | 0.05 | 0.08 | 0.08 | Upgrade
|
Updated Nov 12, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.